Skip to main content

Table 3 ADRs - by system organ class /preferred term, by treatment group and overall

From: Dexketoprofen/tramadol: randomised double-blind trial and confirmation of empirical theory of combination analgesics in acute pain

System organ class

Preferred term

DKP 12.5 mg + TRAM 37.5 mg

DKP 12.5 mg + TRAM 75 mg

DKP 25 mg + TRAM 37.5 mg

DKP 25 mg + TRAM 75 mg

DKP 12.5 mg

DKP 25 mg

TRAM 37.5 mg

TRAM 75 mg

Ibuprofen

Placebo

Overall

n = 61

n = 63

n = 63

n = 61

n = 60

n = 61

n = 59

n = 60

n = 61

n = 62

n = 611

Gastrointestinal disorders

 

3 (4.9)|5

4 (6.3)|4

3 (4.8)|3

6 (9.8)|8

1 (1.7)|1

3 (4.9)|3

0

8 (13.3)|13

1 (1.6)|1

0

29 (4.7)|38

Abdominal pain upper

0

0

0

0

0

0

0

1 (1.7)|1

0

0

1 (0.2)|1

Nausea

3 (4.9)|3

0

0

3 (4.9)|3

1 (1.7)|1

1 (1.6)|1

0

6 (10.0)|7

0

0

14 (2.3)|15

Vomiting

2 (3.3)|2

4 (6.3)|4

3 (4.8)|3

4 (6.6)|5

0

2 (3.3)|2

0

5 (8.3)|5

1 (1.6)|1

0

21 (3.4)|22

General disorders and administration site conditions

 

0

1 (1.6)|1

0

2 (3.3)|2

0

1 (1.6)|1

1 (1.7)|1

0

1 (1.6)|1

0

6 (1.0)|6

Chills

0

1 (1.6)|1

0

0

0

0

0

0

0

0

1 (0.2)|1

Discomfort

0

0

0

1 (1.6)|1

0

0

0

0

1 (1.6)|1

0

2 (0.3)|2

Feeling abnormal

0

0

0

1 (1.6)|1

0

0

0

0

0

0

1 (0.2)|1

Pyrexia

0

0

0

0

0

1 (1.6)|1

1 (1.7)|1

0

0

0

2 (0.3)|2

Nervous System disorders

 

1 (1.6)|1

4 (6.3)|4

1 (1.6)|1

3 (4.9)|3

0

0

2 (3.4)|2

3 (5.0)|4

2 (3.3)|2

0

16 (2.6)|17

Dizziness

1 (1.6)|1

2 (3.2)|2

0

2 (3.3)|2

0

0

1 (1.7)|1

3 (5.0)|3

2 (3.3)|2

0

11 (1.8)|11

Headache

0

0

0

0

0

0

1 (1.7)|1

0

0

0

1 (0.2)|1

Somnolence

0

2 (3.2)|2

1 (1.6)|1

1 (1.6)|1

0

0

0

1 (1.7)|1

0

0

5 (0.8)|5

Psychiatric disorders

 

0

0

0

0

0

0

0

1 (1.7)|1

0

0

1 (0.2)|1

Nervousness

0

0

0

0

0

0

0

1 (1.7)|1

0

0

1 (0.2)|1

Vascular disorders

 

0

0

0

0

0

0

0

1 (1.7)|1

0

0

1 (0.2)|1

Hypotension

0

0

0

0

0

0

0

1 (1.7)|1

0

0

1 (0.2)|1

Overall

 

3 (4.9)|6

6 (9.5)|9

4 (6.3)|4

7 (11.5)|13

1 (1.7)|1

3 (4.9)|4

3 (5.1)|3

10 (16.7)|19

3 (4.9)|4

0

40 (6.5)|63

  1. Results are expressed as number of patients (% of exposed) | number of events